Veritone Inc. Reiterates Q2 and Full Year 2025 Revenue Guidance, Projects Non-GAAP Net Loss Between $30M to $20M for Full Year

Reuters
2025/06/26
<a href="https://laohu8.com/S/VERI">Veritone Inc.</a> Reiterates Q2 and Full Year 2025 Revenue Guidance, Projects Non-GAAP Net Loss Between $30M to $20M for Full Year

Veritone Inc. has released its updated financial guidance for the second quarter and full year 2025. The company anticipates revenue to range between $23.5 million to $24.0 million for Q2 2025, with full-year revenue expected to be between $104.0 million to $115.0 million. The non-GAAP net loss is forecasted to be between $8.5 million to $8.0 million for Q2 2025, and between $30.0 million to $20.0 million for the full year. Veritone has also implemented cost restructuring initiatives designed to streamline operations and enhance financial performance. The company expects these measures to generate annualized savings of up to $10.0 million, with over $7.5 million already realized in June 2025. These efforts are part of Veritone's strategy to position itself for profitability as early as the second half of 2026. Significant business developments include a sole source contract with the United States Air Force, Office of Special Investigations, for deploying aiWARE & iDEMS technologies, and a more than 50% increase in the Veritone Data Refinery (VDR) pipeline since May 2025. Veritone continues to focus on its Public Sector and VDR initiatives as it progresses towards long-term growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veritone Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250625314219) on June 26, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10